Leela Q1: revenue +28% YoY, consolidated PAT ₹49 Cr as deleveraging halves interest cost
PAT +460.3% YoY · revenue +28.08% · margins expanding
₹351.96 Cr
+28.08% YoY
₹48.76 Cr
+460.3% YoY
13.53%
+10.6pp YoY
₹1.45
Leela Palaces Hotels & Resorts (formerly Schloss Bangalore) reported consolidated revenue from operations of ₹351.96 Cr for Q1 FY27, up 28.1% YoY from ₹274.79 Cr, with net profit of ₹48.76 Cr against just ₹8.70 Cr a year ago. Sequentially both fell (revenue −27.3%, PAT −71.6%), but that is the seasonal pattern management explicitly flags — Q4 (Jan–Mar) is the peak for Indian luxury hotels and Q1 (Apr–Jun) the trough — so the QoQ drop is not a deterioration.
Q1 FY-2027 vs prior quarters
The scale of the YoY profit jump (~5.6x) is real but base-flattered: the June-2025 quarter was still carrying pre-IPO leverage, and finance costs have since halved to ₹39.3 Cr from ₹86.0 Cr after the company deployed ₹2,300 Cr of IPO proceeds to repay borrowings. The operating read is cleaner — EBITDA rose 18.7% YoY to ₹151.9 Cr and operating margin (ex-other-income) expanded ~380 bps to 40.7% from 36.9%, lifting net margin to 13.5% from 2.9%. A ₹15.6 Cr share of net loss from joint ventures/associate (versus near-nil a year ago), reflecting ramp-up at newer JV assets, held PBT to ₹64.34 Cr.
The stock went into the print at ₹481.45, up 1.1% over the past month of trading.
For context: PAT has now risen for 3 consecutive quarters.
Management guides for a strong start to FY27 with double-digit revenue and EBITDA growth in Q1, driven by a robust domestic market offsetting recent international travel disruptions which impacted March. For the full year, they anticipate occupancy improving to the low 70s. The company will continue its strategic expan
— This quarter: met
Against management's Q4-FY26 concall guidance of a "strong start to FY27 with double-digit revenue and EBITDA growth in Q1," the print clears the bar on both (revenue +28%, EBITDA +19%). No clean sell-side consensus exists for the quarter given the recent June-2025 listing; broker models (e.g. JM Financial) frame the story as ~18% EBITDA CAGR through FY28 with margins building toward ~49% by FY27, against which Q1's seasonally-soft 40.7% OPM is on-track. Standalone PAT of ₹60.86 Cr exceeds the consolidated figure, but only because of ₹40.65 Cr of inter-company other income at the parent — the consolidated ₹48.76 Cr is the operating picture. Alongside results, the board approved an investment of up to ₹120 Cr into wholly-owned subsidiary Schloss Tadoba for hotel projects, extending a pipeline that already absorbed the ₹559 Cr Coorg resort acquired last quarter. No management press release was available with this filing.
W1
Occupancy building toward management's guided full-year FY27 low-70s (Q1 seasonally soft).
W2
JV/associate loss trend — ₹15.6 Cr drag this quarter as BKC/Dubai assets ramp; watch for narrowing.
W3
Leverage vs guided ~1.6x Net Debt/EBITDA and the ₹39.3 Cr/quarter finance-cost run-rate as Schloss Tadoba (₹120 Cr) and Coorg capex deploy.
Strong operations mask international headwinds; domestic carries FY27
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Buy
confidence 8/10
Grade B
Hit FY27 Q1 'double-digit growth' guidance. Occupancy (67.5%) tracking toward 'low 70s' (on pace but not yet). International recovery claim partially supported (March -10% → June +1%, still weak).
Optimistic
next 1–2 quarters
Very Optimistic
multi-year
Strong operational execution (28% revenue, 41% EBITDA growth, margin expansion to 41%) with proven pricing power and brand strength (ranked #2 globally). Downside: international demand still weak (+1% YoY vs -10% in March), requiring full normalization to hit FY27 double-digit RevPAR guide. Domestic resilience (25% room revenue growth) mitigates near-term risk. Long-term FY30 EBITDA target of ₹2000 Cr backed by 1000+ key pipeline and proven same-store outperformance.
₹352 Cr
Revenue · +28.1% YoY₹48.8 Cr
Reported PAT · +460.3% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
28% operating revenue growth
MET₹352.0 Cr revenue, 28.1% YoY
41% operating EBITDA growth, 41% EBITDA margin
MET₹143.4 Cr EBITDA, ~41% growth and margin achieved
67.5% occupancy vs 63.6% prior year
METOccupancy recovered to 67.5%, 4pp improvement
Domestic room revenue +25%, international recovered to +1% by June
METDomestic revenue +25% YoY at palace hotels; international -10% March to +1% June
Double-digit RevPAR growth, mid-high teens EBITDA growth FY27
OVERSTATEDDependent on full international normalization. International still weak at +1% vs -30% two-year comparison
Earnings quality
What changed since the last call
International room revenue recovery accelerating
UpgradeMarch -10% YoY → June +1% YoY. Trend reversing faster than feared; management expects Oct-Mar peak season to show full recovery vs geopolitical disruption.
Domestic segment structural strength confirmed
UpgradeDomestic room revenue +25% YoY; multi-generational travel, length-of-stay rising, Kids Club additions. Not cyclical; structural shift management reinvested in.
Direct booking contribution doubled
UpgradeWebsite booking 16% vs 8% prior year (Q1 FY26). Direct acquisition cost ~1/3 of OTA; margin flow-through benefit embedded in 41% EBITDA.
HMA fee growth (+86%) dependency
Neutral₹26.2 Cr Q1 run-rate (annualized ~₹100 Cr) driven by 5 new managed property signings last 5 quarters. Sustainable but volatile quarter-to-quarter.
The Q&A
Analysts pressed on pipeline delays (Vaibhav Mule), international recovery credibility (Achal Kumar, Girish Choudhary), EBITDA margin sustainability (Karan Kamdar), and leverage comfort (Karan Khanna). Management held firm: delays limited to ~1Q (Ranthambore fortress stabilization), international recovery confirmed in daily bookings, margins sustained by cost management (67% renewable energy, 2/3 AMC rates renegotiated), leverage 2.5x comfort. No major concessions or guidance cuts.
RevPAR growth drivers, occupancy outlook — Karan Khanna, Ambit Capital
AnsweredOccupancy growth encouraging at 70% on palace portfolio, ADR pressure from intl but mitigated by domestic +25%. Expect strong H2 with intl events, MICE, conferences. Continue double-digit RevPAR growth trajectory.
Tadoba acquisition economics and leverage — Karan Khanna, Ambit Capital
AnsweredTadoba 15-17% YOC. Net debt ₹1332 Cr, 1.6x LTM EBITDA. Comfortable going to 2.5x average if value-accretive. Good cash flows from same-store over 3 years fund capex.
Domestic room revenue durability — Deepak Saha, Ashika Institutional Equities
AnsweredStructural, not cyclical. Investments in multi-gen travel, Kids Clubs, wellness, F&B in Jaipur/Udaipur bearing fruit. Household income growth, discretionary spend on experiences rising. Expect continued growth.
BRICS event impact, rate compression — Deepak Saha, Ashika Institutional Equities
PartialPositive compression and pre/post demand expected. Cannot disclose specifics due to sensitivity. Well-positioned with right delegations. Contractually secured outsized share.
July-August trends, FY27 revenue growth — Achal Kumar, HSBC
AnsweredJuly fared well. Intl business increasing month-on-month, June came even with LY, now 1% growth YoY. August festive, resorts benefit. No headwinds foreseen rest of year. Confident on double-digit RevPAR, mid-high teens EBITDA growth FY27.
FY30 EBITDA ₹2000 Cr target credibility — Achal Kumar, HSBC
DodgedQuestion dropped (line lost). Not directly answered on this call.
International demand incremental vs replacement — Girish Choudhary, Avendus Spark
AnsweredBoth segments equally important, 50-50 mix historically. Intl adds compression, yield uplift on high-demand dates. Domestic staying; both can grow together. Pricing power accrues when intl normalizes fully.
Direct booking sustainability, margin flow-through — Girish Choudhary, Avendus Spark
AnsweredTarget 2/3 direct for full year. Direct cost ~1/3 of OTA. Website 2x growth via AI, revenue management tools, LLM optimization. Margin benefit embedded in 41% EBITDA.
HMA fees run-rate and sustainability — Girish Choudhary, Avendus Spark
AnsweredHMA ongoing business, various fee structures and performance incentives. Managed portfolio expanding. Confident on trajectory given new hotel openings India/intl.
Pipeline delays and project timelines — Vaibhav Mule, Haitong Securities
Answered~1Q delay declared last quarter. All on track now. Jaisalmer and Leela Residences FY27 end. Srinagar/Bandhavgarh CY27 Q4. Agra/Ayodhya/Sikkim/Ranthambore CY28. Ranthambore delayed 2Q due to 400-year fortress wall stabilization, one-time.
Coorg rebranding and revenue ramp — Vaibhav Mule, Haitong Securities
AnsweredResponse great, ADR nearly 2x post-acquisition. EBITDA break-even in Q1 despite ramp-up. Integrating into distribution, loyalty, direct channels. Ramp now phase 2—very on track.
ResortRevPAR outperformance in FTA-dependent markets — Vaibhav Mule, Haitong Securities
AnsweredCustomer voice focus, experience/programming, iconic locations, revenue mgmt rigour. GDS/corporate business strong. Delhi has heads-of-state/delegations. Udaipur/Jaipur for celebrations. High demand-supply imbalance in micro-markets. All hotels unique.
Dubai asset rehab capex timing — Prashant Biyani, Elara Capital
AnsweredOn plan. Handover early CY27, 12-month rehab, rebrand to Leela. No change.
RevPAR growth through occupancy vs ADR management — Prashant Biyani, Elara Capital
AnsweredBoth levers fired: domestic +25%, retail +20%, website +10%+, group business strong. Jaipur/Delhi specific outperformance. Broad-based across portfolio.
Resort occupancy growth drivers — Sumant Kumar, Motilal Oswal
AnsweredFIT share grown significantly. Not just events. Investments in Kids Club, wellness, F&B drives multi-gen travel. High double-digit occupancy and ADR growth in Rajasthan hotels. Year-on-year resorts growing high double-digit.
EBITDA margin 41% sustainability — Karan Kamdar, Choice Institutional Equities
Answered41% is summer quarter seasonal dip (vs 48-50% rest of year). Cost structure disciplined: AMC/procurement renegotiated, 67% renewable energy rising to 75%. Will maintain/grow marginally quarter-on-quarter. Targeting 50% EBITDA baseline.
Mumbai Luxury Residences revenue and timeline — Karan Kamdar, Choice Institutional Equities
PartialLaunch early FY27. Mock-ups done, show-arounds end of year. Move-in early next year. New business model: live-work-play ecosystem. Premium positioning. No specifics on revenue yet.
INR 2000 Cr EBITDA target progress and risk — Akash Gupta, Nomura
AnsweredOn track. Same-store achieved/exceeded targets quarterly. 5 new deals last 5 quarters. Approvals, financing in place. Construction full swing. All value drivers executed (Arq, F&B, retail). Firmly on track.
CY27 openings timing within the year — Akash Gupta, Nomura
AnsweredBoth towards Q4 CY27 (Oct-Dec). Early for Q1 CY27 are Jaisalmer and Leela Mumbai Residences.
Resort occupancy trajectory 3-4 year outlook — Madhav Agarwal, SKP Securities
AnsweredTargeting mid-60s. 12-month market creation via multi-gen travel, Kids Club, programming. Expect occupancy inching toward 60%, then mid-60s over growth trajectory.
City hotel occupancy upside potential — Madhav Agarwal, SKP Securities
AnsweredNo specific target. Focus on ADR and pricing power rather than occupancy push. Luxury hotels operate 80% but we prioritize ADR growth. Can cross 75% but ADR is lever.
HMA fee volatility and sustainability — Abhishek Khanna, Kotak Securities
AnsweredHMA ongoing, half of portfolio. Various fee structures, performance incentives, past key money. Growth %-age may vary but confident trajectory with new hotel openings India/intl.
Coorg EBITDA contribution in Q1 — Abhishek Khanna, Kotak Securities
AnsweredPositive EBITDA contribution, will ramp. Not too significant in overall. Will reach similar margins as other resort hotels.
FY30 EBITDA bridge and ROCE trajectory — Achal Kumar, HSBC (last question)
AnsweredSame-store achieved/exceeded targets. 5 deals signed, new pipeline active. All approvals/financing in place. Double-digit RevPAR growth target. Value drivers executed. ROCE double-digit now, mid-to-high teens after new hotel ramp.
Guidance
FY27 double-digit RevPAR growth on base of 20% RevPAR in Q1 FY26
HighDependent on intl normalization (currently +1% YoY by June, was -10% March). Domestic +25% is stable. Expect H2 intl recovery with peak season (Oct-Mar).
FY27 mid-to-high teens EBITDA growth (implicit from 41% Q1 margin base)
HighOperating leverage confirmed by 383bps YoY margin expansion. Cost mgmt (67% renewable rising to 75%, renegotiated AMC/procurement), revenue growth flow-through.
Maintain/grow EBITDA margins marginally QoQ from 50% baseline
MediumQ1 41% is seasonal summer dip. Expecting return to 48-50% in H2 due to higher tourist demand (intl peak Oct-Mar).
1000+ keys across development pipeline (Srinagar, Bandhavgarh, Ayodhya, Agra, Sikkim, Ranthambore, Tadoba, BKC Mumbai)
MediumCY27 (Srinagar, Bandhavgarh Q4). CY28 (Agra, Ayodhya, Sikkim, Ranthambore). CY30 (Tadoba). Financing and approvals in place.
Risks the call surfaced
International travel demand
HighInternational room revenue still +1% YoY in June vs -10% in March. 30% of mix; was 50% pre-disruption. Concentrated impact if West Asia conflict escalates.
Project execution risk
Medium1000+ keys in 7-project pipeline (CY27-30). Ranthambore fortress stabilization added 2Q delay; Agra/Ayodhya piling just started. Risk of further construction delays.
Dubai JV asset drag
Medium₹156 Cr loss booked on 25% equity-accounted share of Dubai JV. Operationally break-even but accounting loss due to asset debt and depreciation. Leela taking over CY27, 1-year renovation, re-launch as Leela brand.
Occupancy saturation
LowCity hotels occupancy 72% blended FY26; management says no target to push >75% but 'can cross 75%.' Focus is ADR, not volume. If ADR growth decelerates, RevPAR growth capped.
Leverage scaling
LowCurrent 1.6x Net Debt/EBITDA; management willing to go 2.5x for value-accretive M&A. If FY27-28 EBITDA growth misses (e.g., intl stays weak), leverage becomes binding constraint.
Management
Score 7/10. Clear on metrics, transparent on challenges (Dubai JV losses, intl headwinds, Ranthambore delay). CEO provides detailed operational color; CFO disciplined on financial metrics. Some information withheld for 'sensitivity' (BRICS event specifics), justified. Track record strong: Q1 met 'double-digit growth' guidance (28% revenue), achieved 41% EBITDA growth. Same-store hotels consistently hit/exceed targets. Margin expansion 383bps YoY confirms operating leverage. Portfolio expansion on schedule (1Q delay disclosed, being managed).
1 · Sep 2026
BRICS summit Delhi; 20% of palace keys from Delhi location; rate-ups and compression seen in Q1 AI summit
2 · Q4 CY27
Srinagar and Bandhavgarh openings; ~400 combined keys; both heritage/premium segments
3 · FY28-30
Agra, Ayodhya, Sikkim, Ranthambore, Tadoba; 1000+ key ramp-up; 1.4x luxury segment RevPAR outperformance track record
Long-term FY30 EBITDA target of ₹2000 Cr backed by 1000+ key pipeline and proven same-store outperformance.
Strong operations hide a ₹156 Cr loss—and a question about international demand
Headline numbers (28% revenue, 41% EBITDA growth, margin expansion to 41%) are genuine. But the reported PAT of ₹48.8 Cr buries a ₹156 Cr loss from the Dubai JV. Strip it out, and core operating profit was nearly 4x higher—and the real test is whether international demand fully recovers by peak season.
₹48.8 Cr
+460% YoY
₹156 Cr
masks core ops
~₹205 Cr
ex-JV headwind
₹143.4 Cr
+41% YoY, 41% margin
67.5%
vs 63.6% PY, tracking low-70s target
17%
ADR +10%, occupancy +4pp
Where the profit really sits
The reported PAT of ₹48.8 Cr (+460% YoY) looks extraordinary on the surface. But it is weighed down by a ₹156 Cr loss from the Dubai hotel JV (Leela owns 25%, equity-accounted). This loss is temporary. The asset is operationally break-even, and Leela is taking it over in CY27 for a 12-month renovation and rebrand. Strip it out, and core operating profit from owned and managed hotels was ~₹205 Cr—a far more powerful picture of what the quarter actually delivered. The reported number tells you the damage; the adjusted number tells you the strength.
While the Dubai hotel continues to be operational, reduced travel flows due to the West Asia conflict have impacted both occupancy and ADR for the time being. However, the asset is operationally break-even despite this being an off-peak period.
The operational print is solid
28% operating revenue growth
₹352 Cr revenue, 28.1% YoY
Supported ✓
41% EBITDA growth with 41% EBITDA margin
₹143.4 Cr EBITDA, ~41% growth and margin achieved
Supported ✓
67.5% occupancy vs 63.6% prior year
Occupancy recovered to 67.5%, 4pp improvement YoY
Supported ✓
Domestic room revenue +25%, international recovered to +1% by June
Domestic confirmed +25% YoY; intl -10% March → +1% June
Supported (but intl recovery incomplete) ⚠
Double-digit RevPAR growth and mid-to-high teens EBITDA growth FY27
Dependent on full international normalization; intl at +1% YoY vs -10% two years ago
Overstated—hinges on external recovery
The international recovery question
This is where the quarter reveals its dependency. International room revenue recovered from -10% YoY in March to +1% by June, but it remains a headwind. Before the geopolitical disruption, international represented roughly 50% of the revenue mix; it is now 30%. That shift carries material margin and growth implications. Management is confident that the Oct–Mar peak season will show "full recovery," but confidence and confirmation are different things. The FY27 guidance for double-digit RevPAR growth and mid-to-high teens EBITDA growth hinges on this recovery holding.
Management's tone on the call was measured. They reiterated guidance rather than raising it. They acknowledged March weakness and June recovery, and framed both as transient. But they did not promise a return to the 50-50 mix; they said domestic and international "can grow together." This is a credible hedge, not a bold prediction. The market rightly interprets it as: execution has been world-class; demand recovery will be the test.
What changed on this call
Three tangible shifts from the prior quarter:
International momentum visible (March -10% → June +1%). Trend reversing faster than feared; Oct–Mar peak season will confirm or refute full recovery.
Domestic segment confirmed as structural, not cyclical. Room revenue +25%, multi-generational travel rising, length-of-stay extending. Management reinvested in Kids Clubs, wellness, F&B to capture it.
Direct booking distribution doubled (16% vs 8% prior year). Website cost ~1/3 of OTA; margin benefit already embedded in 41% EBITDA.
How the street is positioned
The stock rallied hard post-result: +1.46% day 1, +1.55% day 3, +4.73% by day 5. The market's own verdict: the print was strong enough to justify a move, and the day-5 level suggests it held. The stock is now at ₹510.05, trading above its 20-day, 50-day, and 200-day simple moving averages (₹493.91, ₹479.06, ₹437.28 respectively), sitting 32.65% above its 52-week low but 3.22% below its all-time high. This is a stock that has climbed; the question is whether it has room to run.
Ownership flow tells a more nuanced story. FII ownership fell 75 bps quarter-on-quarter (from 8.62% to 7.87%), while DII ownership rose 101 bps (from 10.51% to 11.52%). The direction matters: foreign institutions took some profits post-rally; domestic institutions bought. This is consistent with a "good but not transformational" earnings print. Promoters remain steady at 75.91%.
The bull-bear ledger
Operational execution is world-class: 28% revenue, 41% EBITDA growth, 383 bps margin expansion, occupancy +4pp. Same-store hotels consistently hit/exceeded targets over 4+ quarters.
Domestic demand is structural, not cyclical. +25% room revenue backed by rising HNI base, multi-generational travel, and Leela's own investments. Repeatable.
Pricing power is real. Brand ranked #2 globally (5th time since 2020), NPS 86, iconic locations, RevPAR outperformance 1.4x luxury sector growth over 6 years. Defensible moat.
Direct bookings doubled; cost 1/3 of OTA. Distribution advantage embedded in current economics, not future upside.
FY30 ₹2,000 Cr EBITDA target (10x FY20) is concrete. Backed by 1,000+ key pipeline with proven 1.4x luxury-segment RevPAR outperformance. Not aspirational.
International recovery is only +1% YoY as of June. Down from -10% in March, but 30% of mix vs prior 50%. If peak season does not show full recovery, FY27 guidance (double-digit RevPAR, mid-high teens EBITDA) will miss.
QoQ decline is sharp: revenue -27%, PAT -71%. This is seasonal (Q1 is trough for luxury hotels), not a quality issue. But it raises quarterly visibility risk.
Dubai JV is temporary, but 25% ownership is material. ₹156 Cr loss in one quarter is manageable; the asset will drag until stabilized post-rebranding (CY27 rehab, CY28 ramp).
Leverage at 1.6x is comfortable, but management willing to 2.5x for value-accretive M&A. If growth disappoints (intl stays weak), leverage becomes binding.
Occupancy upside capped. City hotels at 72%, resorts ~60%; management targeting ADR, not occupancy >75%. If occupancy plateaus and ADR growth slows, RevPAR growth becomes harder.
Risks, ranked by how much they should concern a holder
International demand does not normalize fully by peak season (Oct–Mar FY27)
HighFY27 double-digit RevPAR growth guidance would miss. International is 30% of mix now (vs prior 50%); full recovery required for mid-to-high teens EBITDA growth. If intl stays +1% to +5% YoY, total RevPAR growth drops to mid-single-digits.
Development pipeline delays (Srinagar, Bandhavgarh, Ranthambore, Agra, Ayodhya)
Medium1,000+ key expansion underpins FY30 ₹2,000 Cr EBITDA target. Ranthambore already delayed 2Q (fortress wall stabilization). Further slippage pushes revenue ramp into FY31, risking target credibility.
Dubai JV occupancy/ADR stay depressed (multi-quarter headwind if conflict escalates)
Medium₹156 Cr loss in Q1; loss could recur in Q2–Q3 if West Asia situation worsens. Leela takeover in CY27 will eventually resolve it, but near-term drag on consolidated PAT.
Occupancy growth saturates; ADR growth decelerates
MediumCity hotels at 72% (targeting 75%, not >80%). If occupancy plateaus and domestic leisure ADR softens (macro slowdown), RevPAR growth capped at low single-digits.
Leverage constraint if growth disappoints (FY27–28 EBITDA growth <mid-teens)
Low–MediumCurrent 1.6x Net Debt/EBITDA comfortable. But if FY27 EBITDA growth misses (intl stays weak, occupancy flat), 2.5x ceiling becomes binding and limits capex flexibility for pipeline.
What to watch next
1 · BRICS summit (Sep 12–13, Delhi)
20% of Palace Hotel keys are in Delhi. Q1 saw rate-ups and compression during the AI summit (comparable event). Management expects pre/post demand but will not disclose specifics. If BRICS delivers materially higher rates or occupancy vs. baseline, it is proof-of-concept that events drive pricing power. Watch Delhi occupancy and ADR reported in Q2.
2 · International bookings progression (Jul–Sep leading to peak Oct–Mar season)
Management said July was strong, Aug festive. The real test is whether Sep–Oct forward bookings show international demand returning to 50-50 mix. Monthly international room revenue progression (currently +1% in June) will confirm or refute peak-season normalization. If it reaches +10% to +15% YoY by Sep–Oct, FY27 double-digit RevPAR is on track. If <+5%, guidance is at risk.
3 · Development capex execution (Srinagar, Bandhavgarh Q4 CY27; Agra, Ayodhya CY28)
FY30 ₹2,000 Cr EBITDA target depends on 1,000+ key additions on schedule. Ranthambore's 2Q delay (fortress wall) signals execution risk. Watch capex spend and timeline updates in Q2 call. Further delays weaken FY30 target credibility.
The honest read
Leela delivered a strong operational quarter. The ₹156 Cr Dubai JV loss masks nearly ₹205 Cr in core operating profit. Revenue growth (28%), EBITDA growth (41%), margin expansion (383 bps), and occupancy recovery (+4pp) are all genuine. Management execution has been world-class, and the domestic demand shift is structural.
The stock's +4.73% post-result rally was justified. But the real question—the one that will determine whether FY27 guidance holds and the ₹2,000 Cr FY30 target remains credible—is international demand recovery. A +1% YoY trend in June is not a failure, but it is not a vindication either. Oct–Mar peak season will tell. If international room revenue reaches +10% to +15% YoY in the coming months, the bull case is intact. If it stalls <+5%, the company's ability to deliver double-digit RevPAR and mid-to-high teens EBITDA growth for the full year is compromised.
This is steady, high-quality execution with an external dependency. The number to track from here is monthly international room revenue YoY growth. It is the hinge on which both FY27 delivery and the long-term story turn.